Immunai, a New York and Tel Aviv-based biotech company, announced its acquisition of Dropprint Genomics, a San Francisco-based single-cell genomics software company. The Dropprint team co-founders Meena Subramaniam, PhD, and Rachel Gate, PhD, have also joined the Machine Learning and Computational Biology team at Immunai. This team brings deep experience in genomics and bioinformatics from the University of California, San Francisco.
